These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28043903)

  • 81. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.
    Wassenberg S; Rau R; Steinfeld P; Zeidler H
    Arthritis Rheum; 2005 Nov; 52(11):3371-80. PubMed ID: 16255011
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP).
    Dudley J; Smith G; Llewelyn-Edwards A; Bayliss K; Pike K; Tizard J
    Arch Dis Child; 2013 Oct; 98(10):756-63. PubMed ID: 23845696
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.
    Amini M; Runyon BA
    World J Gastroenterol; 2010 Oct; 16(39):4905-12. PubMed ID: 20954276
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone.
    Mendenhall CL; Anderson S; Garcia-Pont P; Goldberg S; Kiernan T; Seeff LB; Sorrell M; Tamburro C; Weesner R; Zetterman R
    N Engl J Med; 1984 Dec; 311(23):1464-70. PubMed ID: 6390194
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis.
    Weichselbaum L; Azouz A; Smolen KK; Das J; Splittgerber M; Lepida A; Moreno C; Schreiber J; Sersté T; Trepo E; Libert F; Gustot T; Goriely S
    J Hepatol; 2020 Aug; 73(2):303-314. PubMed ID: 32145259
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.
    Mitchell MC; Friedman LS; McClain CJ
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):5-12. PubMed ID: 27979049
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis.
    Lebrec D; Thabut D; Oberti F; Perarnau JM; Condat B; Barraud H; Saliba F; Carbonell N; Renard P; Ramond MJ; Moreau R; Poynard T;
    Gastroenterology; 2010 May; 138(5):1755-62. PubMed ID: 20102716
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.
    Lauterbach R; Pawlik D; Kowalczyk D; Ksycínski W; Helwich E; Zembala M
    Crit Care Med; 1999 Apr; 27(4):807-14. PubMed ID: 10321674
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.
    Boetticher NC; Peine CJ; Kwo P; Abrams GA; Patel T; Aqel B; Boardman L; Gores GJ; Harmsen WS; McClain CJ; Kamath PS; Shah VH
    Gastroenterology; 2008 Dec; 135(6):1953-60. PubMed ID: 18848937
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Invasive aspergillosis in patients with severe alcoholic hepatitis.
    Gustot T; Maillart E; Bocci M; Surin R; Trépo E; Degré D; Lucidi V; Taccone FS; Delforge ML; Vincent JL; Donckier V; Jacobs F; Moreno C
    J Hepatol; 2014 Feb; 60(2):267-74. PubMed ID: 24055548
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparative Effectiveness of Medical Therapies for Severe Alcoholic Hepatitis: Guidance at Last?
    Parikh ND; Schlansky B
    Gastroenterology; 2015 Oct; 149(4):857-9. PubMed ID: 26302486
    [No Abstract]   [Full Text] [Related]  

  • 92. Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.
    Pang JX; Ross E; Borman MA; Zimmer S; Kaplan GG; Heitman SJ; Swain MG; Burak K; Quan H; Myers RP
    Can J Gastroenterol Hepatol; 2015 Apr; 29(3):131-8. PubMed ID: 25855876
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Alcoholic hepatitis: Towards an era of personalised management.
    Degré D; Wandji LCN; Moreno C; Louvet A
    United European Gastroenterol J; 2020 Nov; 8(9):995-1002. PubMed ID: 32718222
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.
    Daswani R; Kumar A; Anikhindi SA; Sharma P; Singla V; Bansal N; Arora A
    Indian J Gastroenterol; 2018 Mar; 37(2):141-152. PubMed ID: 29704174
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis.
    Abu Omar Y; Randhawa T; Attar B; Agrawal R; Wang Y; Pichardo R; Majeed MB; Patel SA
    Cureus; 2019 Nov; 11(11):e6141. PubMed ID: 31886076
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
    Amjad W; Alukal J; Doycheva I; Zhang T; Maheshwari A; Yoo H; Thuluvath PJ
    Dig Dis Sci; 2020 Dec; 65(12):3726-3733. PubMed ID: 32072435
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reticuloendothelial activation correlates with disease severity and predicts mortality in severe alcoholic hepatitis.
    Vijayalekshmi B; Sharma A; Prabhu SB; Nair SC; Mammen J; Goel A; Zachariah UG; Dutta AK; Balasubramanian KA; Elias E; Eapen CE
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e329-e334. PubMed ID: 33470708
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Mehndiratta MM; Rajabally YA
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD002062. PubMed ID: 29185258
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The diagnostic and prognostic significance of liver histology in alcoholic hepatitis.
    Forrest E; Petts G; Austin A; Lloyd K; Wright M; Vergis N; Atkinson S; Masson S; Patch D; Quaglia A; Thursz M; Goldin R
    Aliment Pharmacol Ther; 2021 Feb; 53(3):426-431. PubMed ID: 33326633
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis.
    Tayek JA; Stolz AA; Nguyen DV; Fleischman MW; Donovan JA; Alcorn JM; Chao DC; Asghar A; Morgan TR;
    EClinicalMedicine; 2022 Dec; 54():101689. PubMed ID: 36267499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.